---
title: "ZJJF's wholly-owned subsidiary has obtained a drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231180333.md"
description: "According to the Zhitong Finance APP, ZJJF announced that recently, the company's wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (referred to as \"Jianfeng Pharmaceutical\") received the drug registration certificate for Rosadustat Capsules approved and issued by the National Medical Products Administration [Certificate No.: 2025S00631 (20mg); 2025S00632 (50mg)]. Rosadustat Capsules are indicated for anemia caused by chronic kidney disease (CKD), including patients on dialysis and those not on dialysis"
datetime: "2025-03-10T08:20:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231180333.md)
  - [en](https://longbridge.com/en/news/231180333.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231180333.md)
generator: "portal-rs"
---

# ZJJF's wholly-owned subsidiary has obtained a drug registration certificate

According to the Zhitong Finance APP, ZJJF (600668.SH) announced that recently, the company's wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (referred to as "Jianfeng Pharmaceutical") received the drug registration certificate for Rosasita Capsules approved and issued by the National Medical Products Administration \[Certificate No.: 2025S00631 (20mg); 2025S00632 (50mg)\]. Rosasita Capsules are indicated for anemia caused by chronic kidney disease (CKD), including dialysis and non-dialysis patients

### Related Stocks

- [600668.CN](https://longbridge.com/en/quote/600668.CN.md)

## Related News & Research

- [Humacyte says Phase 3 V007 trial results show ATEV tops fistula for hemodialysis access at one year](https://longbridge.com/en/news/296352370.md)
- [Humacyte says Phase 3 V012 trial shows ATEV extends catheter-free dialysis time in women](https://longbridge.com/en/news/296784335.md)
- [US FAA says antenna relocated after Marine One safety incident](https://longbridge.com/en/news/296946065.md)
- [REG - On the Beach Group - Holding(s) in Company](https://longbridge.com/en/news/296936991.md)
- [11:59 ETRPC Acquires Peracidin® Product Line](https://longbridge.com/en/news/296810234.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**